Skip to content
মভিকল ওরাল পাউডার - Medicine Image

Movicol Oral Powder (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet

Storage: Store below 30° C and in a place protected from light. Do not refrigerate.

মভিকল ওরাল পাউডার Price Information

Per Piece

৳25.00

Per Strip

৳250.00

Per Pack

৳250.00

Pack Size

10's pack

Note: Prices may vary. Contact pharmacy for latest prices.

Description

Movicol (Generic: Polyethylene Glycol 3350 + Electrolytes) is an osmotic laxative oral powder manufactured by Mundipharma (BD) Pvt. Ltd. Primarily prescribed for constipation relief in adults and children above 2 years, it softens hardened stools and treats fecal impaction. Each 13.125g sachet combines macrogol with balanced electrolytes to prevent dehydration during bowel movements.

Priced at ৳25.00 per sachet (10’s pack: ৳250.00), this oral powder requires mixing with water. Adults and children over 12 typically use 1-3 sachets daily for constipation, while fecal impaction treatment involves dissolving 8 sachets in 1L water within 6 hours. The solution must not be refrigerated and should be consumed promptly.

Mechanistically, Movicol increases intestinal water retention via osmotic action, enhancing stool volume and colonic motility. Its electrolyte composition (sodium, potassium) maintains fluid balance without systemic absorption. Side effects like diarrhea or abdominal discomfort are dose-dependent and reversible. Safe for pregnant/breastfeeding women, it shows negligible systemic exposure.

Key considerations include:

  • Avoid concurrent use with antiepileptics due to reduced drug absorption
  • Adjust doses if diarrhea occurs
  • Do not use beyond 3 days for impaction without medical supervision

Dosage & Administration

Adults & adolescents 12+:
Constipation: 1 sachet daily in 125ml water
Fecal impaction: 8 sachets in 1L water within 6 hours
Renal impairment: No dose adjustment required
Do not store prepared solution beyond 6 hours. Follow oral powder administration guidelines.

Side Effects

Generally well tolerated. However side effects like allergic reactions, electrolyte disturbances particularly hyperkalaemia and hypokalaemia, abdominal pain, diarrhea, headache, peripheral edema may appear.

Pregnancy & Lactation

Pregnancy Category: Safe (negligible absorption). Compatible with breastfeeding. No evidence of fetal/infant risk in clinical studies.

Precautions & Warnings

Cardiac patients: Max 2 sachets/hour. Monitor electrolytes in prolonged use. Avoid continuous use beyond 1 week to prevent laxative dependence.

Use in Special Populations

Pediatric (2-12y): Use under medical supervision. Geriatric: No dose adjustment. Renal/Hepatic impairment: Usable without precautions.

Overdose Effects

Severe pain or distention can be treated by nasogastric aspiration. Extensive fluid loss by diarrhea or vomiting may require correction of electrolyte disturbances.

মভিকল ওরাল পাউডার Frequently Asked Questions

⚠️ Disclaimer

At Medexly, we're committed to providing reliable and accessible health information. Please note, however, that all content is for informational purposes only and not intended as medical advice. Our information is collected from pharmaceutical companies, the internet, public sources, and trusted references; therefore, errors or inaccuracies may occur. The information on our website is not legally binding. For personal medical care, always consult a qualified physician. Our goal is to support you with trustworthy information — not to replace the role of a doctor.

Medexly

Related Medicines with Polyethylene Glycol 3350 + Electrolytes

মোভিফাস্ট ওরাল সল্যুশন

(13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml
প্রতি পিস: ৳১৬০

মোভিফাস্ট ওরাল পাউডার

(13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet
প্রতি পিস: ৳২৫

মভিকল ওরাল সল্যুশন

(13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml
প্রতি পিস: ৳৩০৫

More Medicines From Mundipharma (BD) Pvt. Ltd

মভিকল ওরাল সল্যুশন

(13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml
প্রতি পিস: ৳৩০৫

বাংলাদেশের সর্বাধিক ব্যবহৃত ওষুধের তালিকা - জেনেরিক নাম, ব্র্যান্ড, ডোজ ফর্ম এবং ফার্মাসিউটিক্যাল কোম্পানির ভিত্তিতে